Christian Mirescu

Company: Vigil Neuroscience

Job title: Vice President, Head of Neuroimmunology

Seminars:

TREM2 MOLECULAR GLUES: FIRST-IN-CLASS APPROACH TO TUNING MICROGLIA FOR THE TREATMENT OF ALZHEIMER’S DISEASE 2:30 pm

Potent, selective, orally bioavailable, and brain penetrant small molecule TREM2 agonists Leveraging unique pharmacological profiles for precision modulation of microglial function Building a TREM2 translational strategy with CSF biomarkersRead more

day: Conference Day One

Panel Discussion: Evaluating the Current Landscape of Neuroimmunology Therapeutics & Clinical Development Programs 9:00 am

Outlining neuroimmunology targets currently in clinical development Highlighting implications for future neuroimmunological advancements and novel neuroinflammatory targetingRead more

day: Conference Day One